Observed March 21-27, National Poison Prevention Week helps raise awareness about the dangers of poisonings and promotes steps that everyone can take to prevent them.

Meeting brings together 360 stakeholders from across academia, government, and industry to explore methods to develop better models that can identify and accurately predict drug risks and efficacy.

Virtual event brings together more than 500 attendees, including stakeholders from the FDA, academia, and industry.

Experts in geriatric pharmacotherapy and substance use research explore current methods for managing chronic pain in older adults, including potential areas of improvement in patient care and policy.

New non-invasive quality assurance method developed by Dr. Bruce Yu and his team offers more effective way to detect freezing events in vaccines at the point-of-care.

Company spun out of UMB School of Pharmacy aims to leverage its approach — combining modern artificial intelligence (AI) with traditional mechanistic models — to arm health care professionals with the best data to provide personalized treatment trajectories for patients.

Guide published by the Peter Lamy Center on Drug Therapy and Aging and US Deprescribing Research Network offers recommendations to improve resident-centered health and reduce opportunities for transmission of COVID-19 in post-acute and long-term care facilities.

Event organized by the School’s Metallotherapeutics Research Center brings together regional experts with interest in metal systems to stimulate interaction and collaboration.

Well-loved at the School of Pharmacy and the Francis King Carey School of Law, veteran professor is extolled as “an extraordinary teacher and an incredible asset” to UMB.

Leaders in technology and pharmacy collaborate to offer the first technology-enabled adherence solution to fight the country’s deadliest chronic diseases.

Event sponsored by the University of Maryland Center of Excellence in Regulatory Science and Innovation brings together more than 600 researchers from academia, government, and industry.

More than 100 researchers from academia, government, and industry come together to share existing knowledge, new approaches, best practices, and continued challenges in pediatric drug formulation.